Adenoid cystic carcinoma of cervix: two cases report and review of the litterature

Adenoid cystic carcinoma of cervix: two cases report and review of the litterature

 

Khadija Benhayoune^1,&, Hinde El Fatemi¹, Abdelaziz Bannani², Abdelilah Melhouf³, Toufik Harmouch¹

 

¹Laboratory of Surgical Pathology, CHU Hassan II of Fez, Fez, Morocco, ²Department of Gyneacology I, CHU Hassan II of Fez, Fez, Morocco, ³Department of Gyneacology II, CHU Hassan II of Fez, Fez, Morocco

 

 

^&Corresponding author
Khadija Benhayoune, Laboratory of Surgical Pathology, CHU Hassan II of Fez, Fez, Morocco

 

 

 

 

Adenoid cystic carcinoma (ACC) (also called adenocystic carcinoma, cylindroma or cylindromatous adenocarcinoma) is a malignant epithelial neoplasm derived from the salivary glands and can occur in variety of other sites, such as minor and major glands, lacrymal glands, mucous glands of the aero-digestive tract, skin, breast and lung [1,2]. In the female reproductive tract, adenoid cystic carcinoma occurs most commonly in the Bartholin gland and rarely in the cervix [1]. It accounts less than 1% of all cervical carcinoma. A very wide spectrum of pathologic entities has been presented as ACC of the cervix. Billroth in 1859 originally defined this lesion as ‘‘tumor composed of small basal cells with slight eosinophilic cytoplasm, hyperchromatic nuclei in central amorphous eosinophilic mass of varying amounts’’. This definition has been extended today to include tumors where spindle or basal cells predominate. Most of the patients are over 60 years of age, and there is a high proportion of black women [3]. It is characterized by slow grouth and high rate of local recurrence. Metastatic spread is usually a long-term complication [4,5]. Because of the rarety of the disease, no standard treatment has yet been proposed. We report two cases of primary ACC of the cervix and we discuss the clinical, pathological and therapeutic features of disease.

 

 

 

CASE 1

 

A80 years old postmenopausal moroccan woman (para6, gravida6) admitted to our hospital with postmenopausal bleeding and hydrorrhea. Gynealogical examination showed a cervical stenotic with the presence of a tumor processus whose size is diffuclt to assess. On bimanual recto-vaginal examination we showed that the tumor had invaded both sides of the parametrium. Biopsy of cervical growth was done and sent for histopathological examination.

 

CASE 2

 

80-year-old woman presented to Department of gynaecology with vaginal bleeding with pelvic pain. Physical examination revealed a friable mass in the cervix. Bimanual pelvic examination showed that vagina, uterus and bilateral adnexal structures are normal. Speculum examination showed an ulcerative and exophytic mass, 4cm in diameter on the anterior lip of the cervix. The lymph nodes are free. Transabdominal pelvic ultrasound reported that the uterus was with homogenous myometrium, indistinct endometrial echo pattern and bilateral adnexal areas were normal. Incisional biopsy was performed. Microscopic examination showed fragmented biopsy with tumor cells disposed in cribriform nests and cords. The tumor cells were small, uniform, composed of dense basophilic nuclei with inconspious nucleoli. Mitotic figures were rarely found (Figure 1). Immunohistochemical study was performed. Tumor cells express receptors ant-CD117, hormone receptors and focally anti-CK5/6, anti-S-100 protein and anti-CD56. A diagnosis of adenoid cystic carcinoma was made (Figure 2).

 

 

Adenoid cystic carcinoma pattern is best knowen as neoplasm of the major and minor salivary glands. The first case of adenoid cystic carcinoma of the cervix was reported as cylindroma in 1949 by Paalman and Counseller [2,6]. There are no studies that have systematically investigated the incidence of ACC. However, it accounts less than 1% of all cervical carcinoma. The most accepted view regarding its origin in the cervix is from ‘‘reserve cells’’ of endocervix [2]. The origin of this disease is still unknown. Although, Human papillomavirus (HPV) infection is belived to be a necessary cause of cervical cancer, its role in the pathogenesis of ACC is not well defined [4,7]. These tumors usually occurs in postmenopausal women. Though, it has been reported from 24 to 99 years of age, majority of the cases have been reported during 7th to 9th decades of life [2, 8-11]. But, some recent data reported some cases in young woman [4,12,13]. Our patient was postmenopausal and multiparous woman. Although, some authors suggested the association between ACC, highparity and black race [4,14,15]. Clinical and radiological characteristics of primary ACC of the cervix were similar to those of a squamous cell cancer. The main symptom of disease was the vaginal bleeding [4,12]. In addition, vaginal discharge and uterine enlargement can be seen. Clinically, it presents as a nonfriable mass on speculum examination, in contrast to the friable growth usually seen in squamous cell carcinoma of cervix. The details of the gross examination of the surgical specimens were not clearly specified. Seemingly, the gross features of these lesions did not differ from those usually seen in ordinary squamous-cell carcinoma of the cervix. Their size varied from small tumors involing portions of the cervix and invading the parametria. The histologic types of the primary carcinoma of the cervix cannot be classified simply as either a squamous or a gland cell lesion (adenocarcinoma). Despite the fact that there were co-existing components of squamous cell metaplasia or carcinoma of the cerix has been found, by means of election microscopic study, to prossess structures of glandular epithelium [16,17]. This finding suggests that adenoid cystic carcinoma shares the origin from endocervical glands with ordinary cervical adenocarcinoma. The characteristics pathologic features of ACC have been amply documented in several reports. The histologic appearance is varied and includes cribriform, corde-like, glandular and basaloïd patterns, as well as the classical cylindromatous appearance.

 

Cribriform is the most characteristic pattern in ACC and is composed of polygonal to spindled cells forming numerous duct-like structures that contain extracellular matrices filled with homogenous eosinophilic periodic acid-Schiff (PAS) positive material or granular basophilic material [18,19]. The pseudocystic spaces stained positively with antibodies to type IV collagen, laminin, heparan sulfate proteoglycan and entractin. In the tubular type, small ductal structures formed by one or two layers of cuboïdal or polygonal tumor cells were intermingled with solid strands of tumor cells. The lamina of these tubules contained an eosinophilic amorphous material. The solid type is characterized by solid sheets with prominent mitotic activity and frequently with central necrosis. Small clusters of slightly larger polygonal cells are occasionally present. This pattern is morphologically least differentiated and is not diagnostic by itself. Perzin et al. [20,21]described a grading system for ACC based on distinctive histologic patterns: tubular, cribriform and solid. They believed that the three patterns reflect a progression of cellular proliferation and aggressiveness of biologic behavior. The tumor is a assigned to three histologic grades: gradeI,a well-differentiated tumor composed of tubular and cribriform patterns without solid components; grade II: a tumor with a pure cribriform pattern or mixedwith less than 30% of solid aeras and grade III, a tumor with marked predominance of the solid pattern. This tumor has a remarkable tendency for invasion perineural spaces, to the degree that the diagnosis of ACC should be questionned if an adequate sample taken from the periphery of the tumor does not exhibit the feature. This is thought to be caused or promoted by the production of brain- derived neurotopic factor [22]. ACC can also occur in association with other tumor types as an example of squamous or adenocarcinoma tumor components. Immunohistochemically, the tumor cells located in recognizable duct structures express a phenotype similar to that of the the intercalated duct (positive for keratin, S-100 protein and CD117 (C-kit)) and those around pseudocysts have a phenotype suggestive of myoepithelial cell differentiation (positive for S-100 protein and actin and variable for keratin). The patter of c-kit expression in ACC differs with the histologic subtype. Tubular and cribriform variants primarily show C-kit expression in the luminal cell layers. This suggests that myoepithelial cells do not express C-kit as the abluminal cells do not stain [23,24]. Paradoxically, solid variants show expression in all cells, most of which are considered modified myoepithelial cells [23,24]. This suggests the role of C-kit overexpression in the aggressive clinical behavior. There is also strong reactivity for basement membrane components, particularly along the inner luminal surface of the pseudocysts [25]. These components include type IV collagen, laminin, their intergin ligands, heparain sulfate proteoglycan (perlecan) and entactin [19,26,27]. The basement membrane material also stains for alph-1-antitrypsin [28]. Adenoid cystic carcinomas have also been found to express hormone receptors [29] and about a half of them stain for CD34[30].

 

The differential diagnosis includes small cell carcinoma, adenoid basal carcinoma and no-keratinizing squamous cell carcinoma. Furthemore, as already stated, ACC is usually strongly immunoreactive for CD117. Important points to remember are that ACC is usually invasive and often associated with perineurial invasion and that mesenchyme-like areas and foci of squamous metaplasia are consistently absent. ACC of the cervix seems to be more aggressive than squamous cell carcinoma of the cervix with higher tendency to local and metastatic recurrence even if diagnosed in their earliest stages [4,5]. Five years and ten years survival were 37% and 40% respectively [4,31]. In some series, the recurrence rate was 59% for the tubular tumors, 89% for the classic cribriform lesions and 100% for the solid variety. In another series in which a somewhat similar grading system was used, the cumulative survival rates at 5 years were 39%, 26% and 5%, respectively [32]. The solid or anaplasic type of ACC is associated with a higher incidences in which a conventional ACC undergoes dedifferentiation or high-grade transformation [33], an event that is accompanied by TP53 gene mutation [34]. The solid subtype carries a worse prognosis in terms of the development of distant metastases and overall survival. For the solid subtype, control of local disease is not as important a variable for ultimate survival, due to the rapidity of death from distant metastases. The cribriform subtype demonstrated greater local aggressiveness and a poorer salvage rate as compared with the tubular subtype [20]. Other factor that influences the prognosis of ACC is the anatomic site. The lower survival rate is probably explained by the fact that ACC arising in some difficult region impossible to excise completely [35,36]. The presence of tumor at the surgical magin appears to be an important factor in predicting prognosis and the size of the tumor appears also to be one of the most important factor in prognosis. Cure is obtained with much frequency in patients with smaller primary lesions [36]. Factors other than histologic grade and location that appear to inflence survival are the invasion of adjacent anatomic structures, deep stromal invasion and the presence of tumor cells within a lymphatic space or capillary [36]. Abnormalities of E-cadhrin expression have been detected, and the claim has been made that reduced expression of this adhesion molecule correlates with an unfavorable prognosis [37]. Because of the rarity of the disease and the absence of prospective studies, no standard treatment has yet been proposed. Most patients were treated as squamous cell carcinoma. Surgery and radiation therapy has been used in the treatment of ACC of the cervix. The best treatment is surgery, principally when the surgical lines of resection could be histologically determined. Radiotherapy proved to be a useful method of treament for surgically treated patients whose surgical borders were indaquate, those who experienced recurrent disease and those considered inoperable [38]. Chemotherapy has very little role in the management of these tumors but has been used for advanced/recurrent/metastatic disease without much success [2,9,13].

 

 

Adenoid cystic carcinoma of the cervix is a rare and aggressive tumor with fatal outcome. We must think of this tumor in elderly woman and the presence of perineurial invasion. It has a clinical course influenced principally by the clinical staging and the histologic pattern of growth presented by the tumor. The prognosis is also modified by the size and the presence or absence the tumor at the margins. Surgery is the best treatment of this disease and radiotherapy is an important palliative procedure that prolongs the life of the patients who are not cured by surgery.

 

 

The authors indicated no potential conflicts of interest.

 

 

All authors have read and agreed to the final version of this manuscript and have equally contributed to its content and to the management of the case.

 

 

Figure 1: proliferation composed of small basaloid cells with trabecular structures. Cylindromatous structures are present

Figure 2: CD117 immunohistochemestry highlighting tumor cells in the adenoid cystic carcinoma

 

 

1. Kim HK, Sung MW, Chung PS, Rhee CS, Park CI, Kim WH. Adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):721-6. PubMed | Google Scholar


2. Gopal Krishna Maheshwari, Kalpana Sudhir Dave, Manish Kumar Wadhwa, Usha Gopal, Rakesh Shah. Adenoid Cystic Carcinoma Of The Uterine Cervix With Pulmonary Metastasis 11 Years After Radiotherapy: Case Report. Turkish Journal Of Cancer. 2000; 30(4): 181-185. PubMed | Google Scholar


3. Ferry JA, Scully RE. ?Adenoid cystic? carcinoma and adenoid basal carcinoma of the uterine cervix: A study of 28 cases. Am J Surg Pathol. 1988 Feb;12(2):134-44. PubMed | Google Scholar


4. Lalla Kawtar Elhassani, Hind Mrabti, Nabil Ismaili, Youssef Bensouda, Ouafae Masbah, Imane Bekkouch, Khalid Hassouni, Fouad Kettani and Hassan Errihani. Advanced adenoid cystic carcinoma of the cervix: a case report and review of the literature. Cases Journal. 2009; (2):6634. PubMed | Google Scholar


5. Koyfman S, Abidi A, Ravichandran P, Higgins S, Azodi M. Adenoid cystic carcinoma of the cervix. Gynecologic Oncology. 2005 Nov; 99(2):477-80. PubMed | Google Scholar


6. Paalman RJ, Consellor VAS. Cylindroma of the cervix procidentia. Am J Obstet Gynecol. 1949 Jul;58(1):184-7. PubMed | Google Scholar


7. Grayson W, Taylor LF, Cooper K. Adenoid cystic and adenoid basal carcinoma of the uterine cervix: comparative morphologic, mucin, and immunohistochemical profile of two rare neoplasms of putative 'reserve cell' origin. Am J Surg Pathol. 1999 Apr; 23(4):448-58. PubMed | Google Scholar


8. Miles PA, Norris HJ. Adenoid cystic carcinoma of the cervix: An analysis of 12 cases. Obstet Gynecol. 1971 Jul;38(1):103-10. PubMed | Google Scholar


9. Berchuck A, Mullin TJ. Cervical adenoid cystic carcinoma associated with ascites. Gynecol Oncol. 1985 Oct;22(2):201-11. PubMed | Google Scholar


10. King LA, Talledo OE, Gallup DG, Melhus O, Otken LB. Adenoid cystic carcinoma of the cervix in women under age 40. Gynecol Oncol. 1989 Jan;32(1):26-30. PubMed | Google Scholar


11. Musa AG, Hughes RR, Coleman SA. Adenoid cystic carcinoma of the cervix: a report of 17 cases. Gynecol Oncol. 1985 Oct;22(2):167-73. PubMed | Google Scholar


12. Dixit S, Singhal S, Neema J, Soornarayan R, Baboo HA. Adenoid cystic carcinoma of the cervix in a young patient. J Postgrad Med. 1994 Apr-Jun;40(2):94-5. PubMed | Google Scholar


13. Phillips GL, Frye LP. Adenoid cystic carcinoma of the cervix - a case report with implication for chemotherapy treatment. Gynecol Oncol. 1985 Oct;22(2):260-2. PubMed | Google Scholar


14. Fowler WC, Miles PA, Surwit EA, Edelman DA, Walton LA, Phatopuias GJ. Adenoid cystic carcinomaof the cervix; report of 9 cases and a reappraisal.Obstet Genecol. 1978 Sep;52(3):337-42. PubMed | Google Scholar


15. Gallager HS, Simpson CB, Ayala AG. Adenoid cystic carcinoma of the uterine cervix: report of four cases. Cancer. 1971 Jun; 27(6):1398-402. PubMed | Google Scholar


16. Shingleton HM, Lawrence WD, Gore H. Cervical carcinoma with adenoid cystic pattern- a light and electron microscopic study. Cancer. 1981 Apr 1;139(7):799-814. PubMed | Google Scholar


17. Thongbliew Prempree. Management of adenoid cystic carcinoma of the uterine cervix(cylindroma): Report of six cases and Reappraisal of all cases reported in the medical literature. Cancer. October 1980; 46(7): 1631-1635. PubMed | Google Scholar


18. Norio Azumi, Hector Battifora. The cellular composition of adenoid cystic carcinoma: an immunohistochemical study. Cancer. October 1987; 60(7): 1589-1598. PubMed | Google Scholar


19. Cheng J, Saku T, Okabe H, Furthmayr H. Basement membranes in adenoid cystic carcinoma: an immunohistochemical study. Cancer. June 1992; 69(11): 2631-2640. PubMed | Google Scholar


20. Howard M, Matsuba MD, Gershon J. adenoid cystic carcinoma salivary gland carcinoma: a histopathologic review of treatment failure patterns. Cancer. February 1986; 57(3), pages 519-524. PubMed | Google Scholar


21. Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course. Cancer. July 1978; 42(1): 265-282. PubMed | Google Scholar


22. Kowalski PJ, Paulino AF. Perineural invasion in adenoid cystic carcinoma: Its causation/promotion by brain-derived neurotrophic factor. Hum Pathol. 2002 Sep;33(9):933-6. PubMed | Google Scholar


23. Ellis GL, Auclair PL. Adenoid cystic carcinoma In: RosaiJ, SobinLH, editors Atlas of tumor pathology Tumors of the salivary gland Third series Fascicle 17. Washington, DC: Armed Forces Institute of Pathology. 1996; 203-28. PubMed | Google Scholar


24. Carla R, penner DDS andrew L Folpe, MD. c-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol. 2002;15(7):687-691. PubMed | Google Scholar


25. Toida M, Takeuchi J, Hara K, Sobue M, Tsukidate K, Goto K, and Nakashima N. Histochemical studies of intercellular components of salivary gland tumors with special reference to glycosaminoglycan, laminin and vascular elements. Virchows Arch (Pathol Anat). 1984;403(1):15-26. PubMed | Google Scholar


26. Kimura S, Cheng J, Ida H, Hao N, Fujimori Y, and Saku T. Perlecan (heparan sulfate proteoglycan) gene expression reflected in the characteristic histological architecture of salivary adenoid cystic carcinoma. Virchows Arch. 2000; 437: 122-128. PubMed | Google Scholar


27. Loducca SVL, Raitz R, Araujo NS, Araujo VC. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: distinct architectural composition revealed by collagen IV, laminin and their integrin ligands (α2β1 and α3β1). Histopathology. August 2000; 37(2): 118-123. PubMed | Google Scholar


28. Takahashi H, Tsuda N, Fujita S, Tazuka F, Okabe H. immunohistochemical investigation of vimentin, neuron-specific enolase, alpha 1-antichemotrypsin and alpha 7-antitrypsin in adenoid cystic carcinoma of the salivary gland. Acta pathol Jpn. 1990 Sep;40(9):655-64. PubMed | Google Scholar


29. Onzo S, Onizuka M, Sato K, ItoY. Immunohistochemical localization of estradiol, progesterone and progesterone receptor in human salivary glandsand salivary adenoid cystic carcinoma. Cell struct Funct. 1992; 17(3):169-175. PubMed | Google Scholar


30. Seethala RR, LiVolsi VA, Pasha TL, and Zhang PJ. CD43 expression in adenoid cystic carcinomas. Mod Pathol. 2008 Mar;16(2):165-72. PubMed | Google Scholar


31. van Dinh , Woodruff JD. Adenoid cystic and adenoid basal carcinomas of the cervix. Obstet Gynecol. 1985 May; 65(5):705-9. PubMed | Google Scholar


32. Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984 Sep 15;54(6):1062-9. PubMed | Google Scholar


33. Cheuk W, Chan JK, Ngan RK. Dedifferentiation in adenoid cystic carcinoma of salivary gland: an uncommon complication associated with an accelerated clinical course. Am J Surg Pathol. 1999 Apr; 23(4):465-72. PubMed | Google Scholar


34. Chau Y-P, Hongyo T, Aozasa K, Chan JKC. Dedifferentiation of adenoid cystic carcinoma; report of a case implicating p53 gene mutation. Hum Pathol. 2001 Dec; 32(12):1403-7. PubMed | Google Scholar


35. Seaver PR Jr, Kuen PG. Adenoid cystic carcinoma of the salivary glands : a study of 93 cases. Am J Surg. 1979;137(4):449-55. PubMed | Google Scholar


36. Philip A Szanto, Mario A, Luna. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. September 1984; 54(6) 1062-1069. PubMed | Google Scholar


37. Franchi A, Gallo O, Bocciolini C, Franchi L, Paglierani M, Santucci M. ReduicedE-cadherin expression correlates with unfavorable prognosis in adenoid cystic carcinoma of salivary glands of the oral cavity.Am J Clin PAtholo. 1999 Jan;111(1):43-50. PubMed | Google Scholar


38. Antonio G, Nascimento, ANA Lucia P. Adenoid cystic carcinoma of salivary glands: a study of 61 cases with clinicopathologic correlation. Cancer. January 1986; 57(2):312-319. PubMed | Google Scholar